HCPCS Range Inhalation Solutions

• 1 Acetylcysteine, inhalation solution, compounded product, administered through DME, unit dose form, per gram ( J7604 )

• 2 Arformoterol, inhalation solution, FDA approved final product, non-compounded, administered through DME, unit dose form, 15 micrograms ( J7605 )

• 3 Formoterol fumarate, inhalation solution, FDA approved final product, non-compounded, administered through DME, unit dose form, 20 micrograms ( J7606 )

• 4 Levalbuterol, inhalation solution, compounded product, administered through DME, concentrated form, 0.5 mg ( J7607 )

• 5 Acetylcysteine, inhalation solution, FDA-approved final product, non-compounded, administered through DME, unit dose form, per gram ( J7608 )

• 6 Albuterol, inhalation solution, compounded product, administered through DME, unit dose, 1 mg ( J7609 )

• 7 Albuterol, inhalation solution, compounded product, administered through DME, concentrated form, 1 mg ( J7610 )

• 8 Albuterol, inhalation solution, FDA-approved final product, non-compounded, administered through DME, concentrated form, 1 mg ( J7611 )

• 9 Levalbuterol, inhalation solution, FDA-approved final product, non-compounded, administered through DME, concentrated form, 0.5 mg ( J7612 )

• 10 Albuterol, inhalation solution, FDA-approved final product, non-compounded, administered through DME, unit dose, 1 mg ( J7613 )

• 11 Levalbuterol, inhalation solution, FDA-approved final product, non-compounded, administered through DME, unit dose, 0.5 mg ( J7614 )

• 12 Levalbuterol, inhalation solution, compounded product, administered through DME, unit dose, 0.5 mg ( J7615 )

• 13 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, FDA-approved final product, non-compounded, administered through DME ( J7620 )

• 14 Beclomethasone, inhalation solution, compounded product, administered through DME, unit dose form, per milligram ( J7622 )

• 15 Betamethasone, inhalation solution, compounded product, administered through DME, unit dose form, per milligram ( J7624 )

• 16 Budesonide, inhalation solution, FDA-approved final product, non-compounded, administered through DME, unit dose form, up to 0.5 mg ( J7626 )

• 17 Budesonide, inhalation solution, compounded product, administered through DME, unit dose form, up to 0.5 mg ( J7627 )

• 18 Bitolterol mesylate, inhalation solution, compounded product, administered through DME, concentrated form, per milligram ( J7628 )

• 19 Bitolterol mesylate, inhalation solution, compounded product, administered through DME, unit dose form, per milligram ( J7629 )

• 20 Cromolyn sodium, inhalation solution, FDA-approved final product, non-compounded, administered through DME, unit dose form, per 10 milligrams ( J7631 )

• 21 Cromolyn sodium, inhalation solution, compounded product, administered through DME, unit dose form, per 10 milligrams ( J7632 )

• 22 Budesonide, inhalation solution, FDA-approved final product, non-compounded, administered through DME, concentrated form, per 0.25 milligram ( J7633 )

• 23 Budesonide, inhalation solution, compounded product, administered through DME, concentrated form, per 0.25 milligram ( J7634 )

• 24 Atropine, inhalation solution, compounded product, administered through DME, concentrated form, per milligram ( J7635 )

• 25 Atropine, inhalation solution, compounded product, administered through DME, unit dose form, per milligram ( J7636 )

• 26 Dexamethasone, inhalation solution, compounded product, administered through DME, concentrated form, per milligram ( J7637 )

• 27 Dexamethasone, inhalation solution, compounded product, administered through DME, unit dose form, per milligram ( J7638 )

• 28 Dornase alfa, inhalation solution, FDA-approved final product, non-compounded, administered through DME, unit dose form, per milligram ( J7639 )

• 29 Formoterol, inhalation solution, compounded product, administered through DME, unit dose form, 12 micrograms ( J7640 )

• 30 Flunisolide, inhalation solution, compounded product, administered through DME, unit dose, per milligram ( J7641 )

• 31 Glycopyrrolate, inhalation solution, compounded product, administered through DME, concentrated form, per milligram ( J7642 )

• 32 Glycopyrrolate, inhalation solution, compounded product, administered through DME, unit dose form, per milligram ( J7643 )

• 33 Ipratropium bromide, inhalation solution, FDA-approved final product, non-compounded, administered through DME, unit dose form, per milligram ( J7644 )

• 34 Ipratropium bromide, inhalation solution, compounded product, administered through DME, unit dose form, per milligram ( J7645 )

• 35 Isoetharine HCl, inhalation solution, compounded product, administered through DME, concentrated form, per milligram ( J7647 )

• 36 Isoetharine HCl, inhalation solution, FDA-approved final product, non-compounded, administered through DME, concentrated form, per milligram ( J7648 )

• 37 Isoetharine HCl, inhalation solution, FDA-approved final product, non-compounded, administered through DME, unit dose form, per milligram ( J7649 )

• 38 Isoetharine HCl, inhalation solution, compounded product, administered through DME, unit dose form, per milligram ( J7650 )

• 39 Isoproterenol HCl, inhalation solution, compounded product, administered through DME, concentrated form, per milligram ( J7657 )

• 40 Isoproterenol HCl, inhalation solution, FDA-approved final product, non-compounded, administered through DME, concentrated form, per milligram ( J7658 )

• 41 Isoproterenol HCl, inhalation solution, FDA-approved final product, non-compounded, administered through DME, unit dose form, per milligram ( J7659 )

• 42 Isoproterenol HCl, inhalation solution, compounded product, administered through DME, unit dose form, per milligram ( J7660 )

• 43 Mannitol, administered through an inhaler, 5 mg ( J7665 )

• 44 Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams ( J7667 )

• 45 Metaproterenol sulfate, inhalation solution, FDA-approved final product, non-compounded, administered through DME, concentrated form, per 10 milligrams ( J7668 )

• 46 Metaproterenol sulfate, inhalation solution, FDA-approved final product, non-compounded, administered through DME, unit dose form, per 10 milligrams ( J7669 )

• 47 Metaproterenol sulfate, inhalation solution, compounded product, administered through DME, unit dose form, per 10 milligrams ( J7670 )

• 48 Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg ( J7674 )

• 49 Pentamidine isethionate, inhalation solution, compounded product, administered through DME, unit dose form, per 300 mg ( J7676 )

• 50 Terbutaline sulfate, inhalation solution, compounded product, administered through DME, concentrated form, per milligram ( J7680 )

• 51 Terbutaline sulfate, inhalation solution, compounded product, administered through DME, unit dose form, per milligram ( J7681 )

• 52 Tobramycin, inhalation solution, FDA-approved final product, non-compounded, unit dose form, administered through DME, per 300 milligrams ( J7682 )

• 53 Triamcinolone, inhalation solution, compounded product, administered through DME, concentrated form, per milligram ( J7683 )

• 54 Triamcinolone, inhalation solution, compounded product, administered through DME, unit dose form, per milligram ( J7684 )

• 55 Tobramycin, inhalation solution, compounded product, administered through DME, unit dose form, per 300 milligrams ( J7685 )

• 56 Treprostinil, inhalation solution, FDA-approved final product, non-compounded, administered through DME, unit dose form, 1.74 mg ( J7686 )

• 57 Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through DME, 1 microgram ( J7677 )